Press release
2021 Antisense & RNAi Therapeutics Market Industry Key Players, Trends, Demand Analysis Forecast to 2030
Antisense & RNAi Therapeutics Market
The global antisense & rnai therapeutics market is expected to grow from $1.11 billion in 2020 to $1.2 billion in 2021 at a compound annual growth rate (CAGR) of 8.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.79 billion in 2025 at a CAGR of 11%.
The Business Research Company offers "Antisense & RNAi Therapeutics Global Market Report 2021" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.
Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
The antisense & RNAi therapeutics market consists of sales of antisense & RNAi therapeutics products and related services by entities (organizations, sole traders and partnerships) that develop antisense & RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma. In addition to this, antisense & RNAi therapeutics finds its application in curing cancer, infectious diseases, cardiovascular diseases, and genetic disorders.
Some of the key players involved in the Antisense & RNAi Therapeutics Market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A
The countries covered in the global Antisense & RNAi Therapeutics Market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global Antisense & RNAi Therapeutics Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Antisense & RNAi Therapeutics Market Segmentation:
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-market-global-report-2020-30-covid-19-growth-and-change
A Few Points From The Table Of Contents
1. Executive Summary
2. Antisense & RNAi Therapeutics Market Characteristics
3. Antisense & RNAi Therapeutics Market Trends And Strategies
4. Impact Of COVID-19 On Antisense & RNAi Therapeutics
5. Antisense & RNAi Therapeutics Market Size And Growth
....
27. Antisense & RNAi Therapeutics Market Competitive Landscape And Company Profiles
28. Antisense & RNAi Therapeutics Pipeline Analysis
29. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
30. Antisense & RNAi Therapeutics Market Future Outlook and Potential Analysis
31. Appendix
The report covers the trends and market dynamics of the Antisense & RNAi Therapeutics Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/
About Us:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2021 Antisense & RNAi Therapeutics Market Industry Key Players, Trends, Demand Analysis Forecast to 2030 here
News-ID: 2251842 • Views: …
More Releases from The Business research company
Hyperuricemia Drugs Market Overview, Current Trends, and Key Player Analysis
The hyperuricemia drugs market is positioned for significant expansion over the coming years as advances in treatment and growing awareness drive increased demand. With a range of new therapies and a focus on lifestyle management, this sector is expected to evolve dynamically through 2030. Here is a detailed look at the market's growth outlook, key players, trends, and segmentation.
Long-Term Growth Outlook for the Hyperuricemia Drugs Market Size Through 2030 …
Analysis of Key Market Segments Influencing the Hydroxychloroquine Market
The hydroxychloroquine market is positioned for notable expansion over the coming years, driven by ongoing research and evolving healthcare needs. Several factors, including novel drug formulations and a broader range of applications, contribute to this promising outlook. Let's explore how this market is expected to grow, the key players involved, and the segments that are shaping its future trajectory.
Projected Growth Trajectory of the Hydroxychloroquine Market
The hydroxychloroquine market is…
Competitive Landscape: Key Market Leaders and Rising Participants in the Hyaluro …
The global hyaluronic acid market is on track for significant expansion in the coming years, driven by growing applications across healthcare and beauty sectors. As consumer demand shifts toward advanced anti-aging and regenerative treatments, this market is set to experience noteworthy growth supported by technological innovations and sustainable practices. Below is an in-depth look at the market size projections, key players, emerging trends, and segment breakdowns.
Projected Market Growth and Size…
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the H …
The humanoid healthcare assistive robot sector is on the cusp of remarkable expansion, driven by rapid technological advances and increasing demand for automated healthcare solutions. This evolving market is set to transform caregiving and medical assistance through innovative robotics aimed at improving patient outcomes and operational efficiency.
Projected Growth Trajectory of the Humanoid Healthcare Assistive Robot Market
The market size for humanoid healthcare assistive robots is anticipated to surge to…
More Releases for RNA
United States Lead Small Interfering RNA (siRNA) Therapeutics Market at 17.4% CA …
Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM Intelligence research report "Small Interfering RNA (siRNA) Therapeutics Market reached US$ 2.55 billion in 2024 and is expected to reach US$ 12.38 billion by 2033, growing with a CAGR of 17.4% from 2025 to 2033." Rising research and development activities, regulatory approvals, demand for targeted therapies against chronic and rare diseases, and advancements in delivery technologies are fueling growth in the…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
